TreeFrog Therapeutics announces today that it has closed a first seed round of 600,000 euros with the support of regional partners in Nouvelle-Aquitaine. Winner of the i-LAB national innovation competition in 2018, the startup will industrialize a disruptive technology for the production of stem cells. Objective: to lower the cost of cellular therapies.